Inhaled steroid/long-acting β2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients

BACKGROUND: The combination of inhaled corticosteroids (ICS) and long-acting β2-agonists (LABA) is recommended by treatment guidelines for the treatment of persistent asthma. Two such combination products, salmeterol/fluticasone propionate (SFC, Seretide™ GSK, UK) and formoterol/budesonide (FBC, Sym...

Descripción completa

Detalles Bibliográficos
Autores principales: Lötvall, Jan, Langley, Stephen, Woodcock, Ashley
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570354/
https://www.ncbi.nlm.nih.gov/pubmed/16919161
http://dx.doi.org/10.1186/1465-9921-7-110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570354/
https://www.ncbi.nlm.nih.gov/pubmed/16919161
http://dx.doi.org/10.1186/1465-9921-7-110

Ejemplares similares